Control of Myopia Using Novel Spectacle Lens Designs — CYPRESS

Juvenile Myopia Clinical Trial

Official title:
Efficacy and Safety Study of Novel Spectacle Lens Designs to Control of Myopia

Status Active, not recruiting

Clinical Trial Summary

Randomized, controlled, multisite, subject-and observer-masked, 3-arm parallel group clinical trial of 36-month duration to evaluate the safety and efficacy of a novel spectacle lens design in reducing the progression of juvenile myopia.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03623074
Study type	Interventional
Source	SightGlass Vision, Inc.
Contact
Status	Active, not recruiting
Phase	N/A
Start date	July 16, 2018
Completion date	June 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06034327` - Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens	N/A
Active, not recruiting	`NCT05893979` - Myopia Control Spectacle Lens Cessation Study	N/A
Active, not recruiting	`NCT04947735` - CYPRESS Efficacy and Safety Study Extension	N/A
Active, not recruiting	`NCT05617794` - Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness	N/A
Active, not recruiting	`NCT05562622` - Assessment of DOT Spectacles in Chinese Children	N/A
Completed	`NCT05650190` - Spectacle Lens Visual Acuity Assessments Study	N/A
Completed	`NCT04126057` - Myopia Assessment of Two Manufacturing Processes	N/A